FACTs to remember On May 14, 2021 Zena announce Q1-2021 results (Covers up to March 31):
- Quantity of cannabis sold totaled 4,753 kg in Q1 2021, which was 27% greater compared to 3,730 kg in Q1 2020;
- Consolidated gross revenue totaled $16.2 million in Q1 2021, 8% higher than $15.0 million in q1 2020;
- Gross margin before fair value changes to biological assets and inventories was $2.7 million or 21.5% of net revenue in Q1 2021, compared to $5.0 million or 39.7% of net revenue in Q1 of the prior year;
- Consolidated Adjusted EBITDA for the quarter totaled a loss of $1.9 million, compared to loss of $768 thousand in Q1 2020;
- Consolidated net income for the quarter totaled $9.1 million or $0.01 per share, fully diluted, compared to a loss of $7.8 million or $0.02 per share, fully diluted, in the same quarter of last year;
On June 1, 2021 Hexo/Zena announce closing of megrer.Zenabis Q2-2021 (covers April - June 30) was NOT released.
Hexo Q3-2021 (Feb - April 30) did not include any of Zenabis numbers.
?? Hexo Q4-2021 (May - July 31) How many Zena month would it include 2 or 4 months?
Beside Zena's positive EPS Q1, Zenabis expects to commence recurring commercial exports to the European Union during Q2 2021 with the first shipment to be completed in May 2021.
In March 2021, Zenabis announced the launch of new 10 and 20 pack configurations of pre-roll.
During the quarter, the Company introduced three new high-THC strains to market and continued development of four additional new strains which are expected to be commercialized in the second quarter of the year.
Above are the reasons why I believe Q4-2021 SHOULD BE good not the greatest, if I don't, I would be smart enough to sell and buy again next week. next Q1 SHOULD BE better, and next Q2 SHOULD BE the best.